- Home
- SFHG vs DCTH Comparison
SFHG vs DCTH Comparison
Compare SFHG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- DCTH
- Stock Information
- Founded
- SFHG 1993
- DCTH 1988
- Country
- SFHG Hong Kong
- DCTH United States
- Employees
- SFHG N/A
- DCTH N/A
- Industry
- SFHG Publishing
- DCTH Medical/Dental Instruments
- Sector
- SFHG Consumer Discretionary
- DCTH Health Care
- Exchange
- SFHG Nasdaq
- DCTH Nasdaq
- Market Cap
- SFHG 323.1M
- DCTH 305.2M
- IPO Year
- SFHG 2024
- DCTH N/A
- Fundamental
- Price
- SFHG $12.99
- DCTH $9.89
- Analyst Decision
- SFHG
- DCTH Strong Buy
- Analyst Count
- SFHG 0
- DCTH 4
- Target Price
- SFHG N/A
- DCTH $21.50
- AVG Volume (30 Days)
- SFHG 723.8K
- DCTH 423.3K
- Earning Date
- SFHG 11-29-2024
- DCTH 11-08-2024
- Dividend Yield
- SFHG N/A
- DCTH N/A
- EPS Growth
- SFHG N/A
- DCTH N/A
- EPS
- SFHG N/A
- DCTH N/A
- Revenue
- SFHG $15,011,245.00
- DCTH $22,644,000.00
- Revenue This Year
- SFHG N/A
- DCTH $1,562.76
- Revenue Next Year
- SFHG N/A
- DCTH $117.72
- P/E Ratio
- SFHG N/A
- DCTH N/A
- Revenue Growth
- SFHG N/A
- DCTH 945.91
- 52 Week Low
- SFHG $4.62
- DCTH $2.60
- 52 Week High
- SFHG $15.94
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- SFHG N/A
- DCTH 47.91
- Support Level
- SFHG N/A
- DCTH $9.50
- Resistance Level
- SFHG N/A
- DCTH $10.04
- Average True Range (ATR)
- SFHG 0.00
- DCTH 0.64
- MACD
- SFHG 0.00
- DCTH -0.12
- Stochastic Oscillator
- SFHG 0.00
- DCTH 23.82
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.